Propel Bio Management, LLC Portfolio Holdings

Propel Bio Management, LLC

  • $86.1 Billion
  • Q1 2025

Propel Bio Management, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $86.1 Billion distributed in 18 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Plains Gp Holdings LP with a value of $27.2B, Madrigal Pharmaceuticals, Inc. with a value of $9.95B, Akero Therapeutics, Inc. with a value of $9.27B, Phathom Pharmaceuticals, Inc. with a value of $7.12B, and Achieve Life Sciences Inc with a value of $6.55B.

Examining the 13F form we can see an decrease of $14.6B in the current position value, from $101B to 86.1B.

Propel Bio Management, LLC is based out at Los Angeles, CA

Below you can find more details about Propel Bio Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $86.1 Billion
Healthcare: $50.8 Billion
Energy: $27.2 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.67B
$27.2 Billion 31.57% of portfolio
1,272,360
Q3 2024 Reduced 7.29%
$4.88B
$9.95 Billion 11.56% of portfolio
30,032
Q1 2025 Reduced 30.21%
$2.55B
$9.27 Billion 10.76% of portfolio
228,884
Q1 2025 Reduced 33.41%
$413M
$7.12 Billion 8.27% of portfolio
1,134,927
Q1 2025 Added 14.65%
Achieve Life Sciences Inc
-
$6.55 Billion 7.61% of portfolio
-
Q1 2024 New
$16.3M
$5.52 Billion 6.41% of portfolio
11,285,420
Q1 2025 Added 17.37%
$1.55B
$5.27 Billion 6.12% of portfolio
178,500
Q4 2023 New
$35.7M
$2.97 Billion 3.45% of portfolio
624,022
Q3 2024 Reduced 50.0%
$29.2M
$2.88 Billion 3.35% of portfolio
2,087,139
Q4 2023 New
$126M
$2.26 Billion 2.63% of portfolio
177,600
Q1 2025 Added 944.71%
$565M
$2.25 Billion 2.62% of portfolio
183,259
Q4 2024 Added 37.52%
$170M
$1.35 Billion 1.57% of portfolio
179,874
Q3 2024 New
$52.8M
$1.16 Billion 1.35% of portfolio
1,451,557
Q1 2025 New
Maat Pharma Saca
-
$1.04 Billion 1.21% of portfolio
-
Q1 2025 Added 5,181.59%
$239M
$434 Million 0.5% of portfolio
228,317
Q1 2025 New
$12.5M
$425 Million 0.49% of portfolio
1,492,792
Q4 2023 New
Chinook Therapeutics
-
$38.5 Million 0.04% of portfolio
-
Q4 2023 New

Summary

  • Portfolio
  • No. of Stocks 18
  • Current Value $86.1 Billion
  • Prior Value $101 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 2 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Propel Bio Management, LLC Portfolio

Follow Propel Bio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Propel Bio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Propel Bio Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email